5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail

Biochemical Journal

Volumn 436, Issue 3, 2011, Pages 651-660

  Barclay, Zoë ^a   Dickson, Louise ^a   Robertson, Derek N ^a,c   Johnson, Melanie S ^a   Holland, Pamela J ^a   Rosie, Roberta ^a   Sun, Liting ^a   Fleetwood Walker, Sue ^a   Lutz, Eve M ^b   Mitchell, Rory ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

5 hydroxytryptamine 2A (5 HT2A) receptor; ADP ribosylation factor (ARF); Co immunoprecipitation; Glutathione transferase (GST) fusion protein; Phospholipase D (PLD); Schizophrenia; Signalling complex

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; G PROTEIN COUPLED RECEPTOR; GLUTATHIONE TRANSFERASE; GLYCOSYLPHOSPHATIDYLINOSITOL PHOSPHOLIPASE D; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; PHOSPHOLIPASE D1; SEROTONIN 2A RECEPTOR; PHOSPHOLIPASE D;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; METABOLISM; PHYSIOLOGY;

ADP-RIBOSYLATION FACTORS; AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; PHOSPHOLIPASE D; RECEPTOR, SEROTONIN, 5-HT2A; SIGNAL TRANSDUCTION;

EID: 79957770499     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101844     Document Type: Article

References (49)

1. Dean, B. (2003) The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice. J. Neurochem. 85, 1-13
2. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R. and Humphrey, P. P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203 (Pubitemid 24185150)
3. Roth, B. L., Willins, D. L., Kristiansen, K. and Kroeze, W. K. (1998) 5-Hydroxytryptamine2- family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol. Ther. 79, 231-257
4. Gonzalez-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q. et al. (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53, 439-452 (Pubitemid 46161267)
5. Banes, A., Florian, J. A. and Watts, S. W. (1999) Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J. Pharmacol. Exp. Ther. 291, 1179-1187
6. Quinn, J. C., Johnson-Farley, N. N., Yoon, J. and Cowen, D. S. (2002) Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases. J. Pharmacol. Exp. Ther. 303, 746-752
7. Gooz, M., Gooz, P., Luttrell, L. M. and Raymond, J. R. (2006) 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-α-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. J. Biol. Chem. 281, 21004-21012
8. Schmid, C. L., Raehal, K. M. and Bohn, L. M. (2008) Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo. Proc. Natl. Acad. Sci. U.S.A. 105, 1079-1084
9. Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P. and Clarke, W. P. (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol. Pharmacol. 54, 94-104
10. Kurrasch-Orbaugh, D. M., Parrish, J. C., Watts, V. J. and Nichols, D. E. (2003) A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases. J. Neurochem. 86, 980-991
11. Guillet-Deniau, I., Burnol, A. F. and Girard, J. (1997) Identification and localization of a skeletal muscle serotonin 5-HT2A receptor coupled to the Jak/STAT pathway. J. Biol. Chem. 272, 14825-14829
12. Johnson-Farley, N. N., Kertesy, S. B., Dubyak, G. R. and Cowen, D. S. (2005) Enhanced activation of Akt and extracellular-regulated kinase pathways by simultaneous occupancy of Gq-coupled 5-HT2A receptors and Gs-coupled 5-HT7A receptors in PC12 cells. J. Neurochem. 92, 72-82 (Pubitemid 40193510)
13. Abbas, A. I., Yadav, P. N., Yao, W. D., Arbuckle, M. I., Grant, S. G., Caron, M. G. and Roth, B. L. (2009) PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. J. Neurosci. 29, 7124-7136
14. Mitchell, R., McCulloch, D., Lutz, E., Johnson, M., MacKenzie, C., Fennell, M., Fink, G., Zhou, W. and Sealfon, S. C. (1998) Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature 392, 411-414
15. Robertson, D. N., Johnson, M. S., Moggach, L. O., Holland, P. J., Lutz, E. M. and Mitchell, R. (2003) Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor. Mol. Pharmacol. 64, 1239-1250
16. Johnson, M. S., Robertson, D. N., Holland, P. J., Lutz, E. M. and Mitchell, R. (2006) Role of the conserved NPxxY motif of the 5-HT2A receptor in determining selective interaction with isoforms of ADP-ribosylation factor (ARF). Cell. Signalling 18, 1793-1800 (Pubitemid 44216132)
17. Kurrasch-Orbaugh, D. M., Watts, V. J., Barker, E. L. and Nichols, D. E. (2003) Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves. J. Pharmacol. Exp. Ther. 304, 229-237
18. Moya, P. R., Berg, K. A., Gutierrez-Hernandez, M. A., Saez-Briones, P., Reyes-Parada, M., Cassels, B. K. and Clarke, W. P. (2007) Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J. Pharmacol. Exp. Ther. 321, 1054-1061
19. Fensome, A., Whatmore, J., Morgan, C., Jones, D. and Cockcroft, S. (1998) ADP-ribosylation factor and Rho proteins mediate fMLP-dependent activation of phospholipase D in human neutrophils. J. Biol. Chem. 273, 13157-13164
20. Shome, K., Rizzo, M. A., Vasudevan, C., Andresen, B. and Romero, G. (2000) The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle A10 cells is mediated by small G proteins of the ADP-ribosylation factor family. Endocrinology 141, 2200-2208 (Pubitemid 32274374)
21. McCulloch, D. A., Lutz, E. M., Johnson, M. S., Robertson, D. N., MacKenzie, C. J., Holland, P. J. and Mitchell, R. (2001) ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant. Mol. Pharmacol. 59, 1523-1532
22. Heuss, C. and Gerber, U. (2000) G-protein-independent signaling by G-protein-coupled receptors. Trends Neurosci. 23, 469-475
23. Rajagopal, K., Lefkowitz, R. J. and Rockman, H. A. (2005) When 7 transmembrane receptors are not G protein-coupled receptors. J. Clin. Invest. 115, 2971-2974
24. Sun, Y., McGarrigle, D. and Huang, X. Y. (2007) When a G protein-coupled receptor does not couple to a G protein. Mol. Biosyst. 3, 849-854
25. Koch, T., Brandenburg, L. O., Schulz, S., Liang, Y., Klein, J. and Hollt, V. (2003) ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced mu-opioid receptor endocytosis. J. Biol. Chem. 278, 9979-9985
26. Bhattacharya, M., Babwah, A. V., Godin, C., Anborgh, P. H., Dale, L. B., Poulter, M. O. and Ferguson, S. S. (2004) Ral and phospholipase D2-dependent pathway for constitutive metabotropic glutamate receptor endocytosis. J. Neurosci. 24, 8752-8761 (Pubitemid 39362970)
27. Du, G., Altshuller, Y. M., Kim, Y., Han, J. M., Ryu, S. H., Morris, A. J. and Frohman, M. A. (2000) Dual requirement for rho and protein kinase C in direct activation of phospholipase D1 through G protein-coupled receptor signaling. Mol. Biol. Cell 11, 4359-4368
28. Yu, B., Gu, L. and Simon, M. I. (2000) Inhibition of subsets of G protein-coupled receptors by empty mutants of G protein α subunits in Go, G11, and G16. J. Biol. Chem. 275, 71-76
29. Klein, J., Iovino, M., Vakil, M., Shinozaki, H. and Loffelholz, K. (1997) Ontogenetic and pharmacological studies on metabotropic glutamate receptors coupled to phospholipase D activation. Neuropharmacology 36, 305-311 (Pubitemid 27198690)
30. Mitchell, P. R. and Martin, I. L. (1978) Is GABA release modulated by presynaptic receptors? Nature 274, 904-905
31. Mitchell, R., Robertson, D. N., Holland, P. J., Collins, D., Lutz, E. M. and Johnson, M. S. (2003) ADP-ribosylation factor-dependent phospholipase D activation by the M3 muscarinic receptor. J. Biol. Chem. 278, 33818-33830
32. Lee, Y. C., Block, G., Chen, H., Folch-Puy, E., Foronjy, R., Jalili, R., Jendresen, C. B., Kimura, M., Kraft, E., Lindemose, S. et al. (2008) One-step isolation of plasma membrane proteins using magnetic beads with immobilized concanavalin A. Protein Expr. Purif. 62, 223-229
33. Ichikawa, J. and Meltzer, H. Y. (1995) DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Res. 698, 204-208
34. Pehek, E. A., Nocjar, C., Roth, B. L., Byrd, T. A. and Mabrouk, O. S. (2006) Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 31, 265-277 (Pubitemid 43113392)
35. Scott, S. A., Selvy, P. E., Buck, J. R., Cho, H. P., Criswell, T. L., Thomas, A. L., Armstrong, M. D., Arteaga, C. L., Lindsley, C. W. and Brown, H. A. (2009) Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat. Chem. Biol. 5, 108-117
36. Lavieri, R., Scott, S. A., Lewis, J. A., Selvy, P. E., Armstrong, M. D., Brown, A. H. and Lindsley, C. W. (2009) Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity. Bioorg. Med. Chem. Lett. 19, 2240-2243
37. Schmidt, M., Huwe, S. M., Fasselt, B., Homann, D., Rumenapp, U., Sandmann, J. and Jakobs, K. H. (1994) Mechanisms of phospholipase D stimulation by m3 muscarinic acetylcholine receptors. Evidence for involvement of tyrosine phosphorylation. Eur. J. Biochem. 225, 667-675
38. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A. and Connelly, P. A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and Fyn-dependent T cell activation. J. Biol. Chem. 271, 695-701
39. Tian, G., Cory, M., Smith, A. A. and Knight, W. B. (2001) Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines. Biochemistry 40, 7084-7091
40. Hammond, S. M., Jenco, J. M., Nakashima, S., Cadwallader, K., Gu, Q., Cook, S., Nozawa, Y., Prestwich, G. D., Frohman, M. A. and Morris, A. J. (1997) Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-α. J. Biol. Chem. 272, 3860-3868
41. Lehmann, D. M., Seneviratne, A. M. and Smrcka, A. V. (2008) Small molecule disruption of G-protein βγ subunit signaling inhibits neutrophil chemotaxis and inflammation. Mol. Pharmacol. 73, 410-418
42. Du, G., Altshuller, Y. M., Vitale, N., Huang, P., Chasserot-Golaz, S., Morris, A. J., Bader, M. F. and Frohman, M. A. (2003) Regulation of phospholipase D1 subcellular cycling through coordination of multiple membrane association motifs. J. Cell Biol. 162, 305-315
43. Zeniou-Meyer, M., Zabari, N., Ashery, U., Chasserot-Golaz, S., Haeberle, A. M., Demais, V., Bailly, Y., Gottfried, I., Nakanishi, H., Neiman, A. M. et al. (2007) Phospholipase D1 production of phosphatidic acid at the plasma membrane promotes exocytosis of large dense-core granules at a late stage. J. Biol. Chem. 282, 21746-21757
44. Du, G., Huang, P., Liang, B. T. and Frohman, M. A. (2004) Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol. Biol. Cell 15, 1024-1030
45. Rankovic, M., Jacob, L., Rankovic, V., Brandenburg, L. O., Schroder, H., Hollt, V. and Koch, T. (2009) ADP-ribosylation factor 6 regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2. Cell. Signalling 21, 1784-1793
46. Rizzo, M. and Romero, G. (2002) Pharmacological importance of phospholipase D and phosphatidic acid in the regulation of the mitogen-activated protein kinase cascade. Pharmacol. Ther. 94, 35-50
47. Garrido, J. L., Wheeler, D., Vega, L. L., Friedman, P. A. and Romero, G. (2009) Role of phospholipase D in parathyroid hormone type 1 receptor signaling and trafficking. Mol. Endocrinol. 23, 2048-2059
48. Perez-Mansilla, B., Ha, V. L., Justin, N., Wilkins, A. J., Carpenter, C. L. and Thomas, G. M. (2006) The differential regulation of phosphatidylinositol 4-phosphate 5-kinases and phospholipase D1 by ADP-ribosylation factors 1 and 6. Biochim. Biophys. Acta 1761, 1429-1442
49. Cockcroft, S. (2009) Phosphatidic acid regulation of phosphatidylinositol 4-phosphate 5-kinases. Biochim. Biophys. Acta 1791, 905-912